Business Wire

Xago Africa and Alevo Analytics Partner with US Trade and Development Agency to Provide Technical Assistance for Energy Storage in Kenya


USTDA is partnering with Kenyan renewable energy developer Xago Africa and US battery storage manufacturer Alevo USA, Inc and analytics service provider Alevo Analytics to support the development of a utility scale solar photovoltaic power plant with integrated battery storage in Siaya County, Kenya. The project will utilize battery storage technology from Alevo and will be among the first utility-scale battery storage installations in Africa.

This Smart News Release features multimedia. View the full release here:

U.S. Ambassador to Kenya, Robert F. Godec, signs the grants on behalf of USTDA, along with Xago Afri ...

U.S. Ambassador to Kenya, Robert F. Godec, signs the grants on behalf of USTDA, along with Xago Africa Managing Director, Paul W. Webb. (Photo: Business Wire)

A $1.4 million technical study supported by the partnership will also provide detailed analytics for the Kenyan power system and serve as a roadmap to help advance the energy storage market in Kenya. Implementation of energy storage technologies can increase the efficiency and stability of the national grid, allow for increased integration of renewable energy generation sources, and reduce reliance on expensive fossil fuel generation in Kenya.

"Our primary focus is on solar energy which has the potential to eliminate the power shortages that hold back socio-economic development across the continent,” said Paul W Webb, Xago Africa’s Managing Director. “Furthermore, energy storage will transform electricity transmission networks and rapidly accelerate the take‐up of renewables, and we are proud to be partnering Alevo which leads the field in battery technology and network analytics. This USTDA funded project builds on our valuable relationship with Power Africa and will lay the foundations for the Kenyan electricity system to become the most advanced in Africa."

“Solar plus energy storage will enable Kenya to increase the adoption of renewable energy as the storage will provide grid stability, help to manage solar intermittency, and provide dispatchability of clean reliable and sustainable power to the Kenyan people,” confirmed Dr Randell M Johnson, PE, Chief Analytics Officer, Alevo Analytics.

Julian Oteng, Xago Africa’s Director of Operations, said “We are also looking at expanding into other territories. Energy storage is coming and we aim to lead the way in North and Sub‐Saharan Africa with Alevo Battery Technology. This is the start of a long-term relationship which will help to bring clean power to the 600 million Africans who do not have access to electricity.”

“USTDA is pleased to facilitate new business partnerships between US and Kenyan companies that can spur long-term, sustainable economic growth,” said Sub-Saharan Africa Regional Director Lida Fitts. “The adoption of innovative and cost-effective US technology can help Kenya to meet its energy development goals.”

Xago Africa is currently developing a 40 MW solar power plant at a cost of around $75 million near Lake Victoria which will alleviate the chronic power shortages in Western Kenya. And together with construction partner, Solarcentury East Africa, Xago Africa will provide solar power systems to three schools in the area in addition to its ongoing support for the Mama Sarah Obama Foundation’s school building programme.

About Xago Africa

Xago Africa was established in 2014 to deliver vital public infrastructure projects financed by private sector funding with the aim of fostering economic growth and sustainable industrial development in Africa. Headquartered in Kenya, Xago Africa combines environmental engineering and project development capabilities with an extensive investor network to accelerate socio‐economic development for the people of Africa.

About Alevo

Alevo®, a leading provider of energy storage is redefining energy as a developer, manufacturer and provider of grid‐scale energy storage solutions featuring GridBank® & Alevo Analytics. GridBank lithium‐ion batteries feature a proprietary inorganic electrolyte (Alevolyte™), which is non-flammable and offers extreme long life and stability. Alevo’s vertically engineered turnkey energy storage solution can be placed anywhere on the electricity supply chain, to reduce energy waste, lower greenhouse gases and other emissions, create efficiencies and lower costs. Founded in 2009, Alevo is headquartered in Switzerland with GridBank manufacturing in the US.

About Alevo Analytics

Alevo Analytics provides advanced energy storage and network analytics, simulation capabilities, business intelligence and advisory services with a primary focus on the power and energy sectors. Alevo Analytics offers Consulting Services, Analytics IQ databases and its GridMaestro™ product suite of real time software solutions for remote operation and control of energy storage with SCADA, SSE Stacked Services Emulator, Data Collector and Master Controller.


The US Trade and Development Agency helps companies create US jobs through the export of US goods and services for priority development projects in emerging economies. USTDA links US businesses to export opportunities by funding project preparation and partnership building activities that develop sustainable infrastructure and foster economic growth in partner countries.

Contact information

AxiCom PR for Alevo
James Kennedy
+44 20 7559 5624

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28Pressemelding

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05Pressemelding

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52Pressemelding

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50Pressemelding

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00Pressemelding

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on